Associate Professor, Pediatrics, University of Washington School of Medicine
Pediatric Hematology & Oncology
Dr. Soheil Meshinchi, MD
|
|
Give Review
Soheil Meshinchi works in the field of Pediatric Hematology & Oncology. He went to medical school at Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63 in research and 85 in primary care medicine Dr. Soheil Meshinchi is also published. He has 28 publications published. The lastest publication: "CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.'
Publications
- CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.
- Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD Acute myeloid leukemia.
- Pediatric Acute Myeloid Leukemia: Biology and Therapeutic Implications of Genomic Variants.
- The outcome of allogeneic hematopoietic cell transplantation for children with FMS-like tyrosine kinase 3 internal tandem duplication-positive Acute myelogenous leukemia.
- Elevated fluoride levels and periostitis in pediatric hematopoietic stem Cell transplant recipients receiving long-term voriconazole.
- AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent Acute myeloid ...
- High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric Acute myeloid leukemia: a report from the Children's Oncology Group.
- Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncolog...
- Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human Acute myeloid leukemia.
- Somatic characterization of pediatric Acute myeloid leukemia using next-generation sequencing.
- Differences in outcomes of newly diagnosed Acute myeloid leukemia for adolescent/young adult and younger patients: A Report from the Children's Oncology Group.
- High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric Acute myeloid leukaemia: a report from the children's oncology...
- The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group.
- Hematopoietic cell transplantation in high-risk childhood Acute myelogenous leukemia.
- A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed Acute myeloid leukaemia.
- Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo Acute...
- Significance of expression of ITGA5 and its splice variants in Acute myeloid leukemia: A report from the Children's Oncology Group.
- Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin-Contai...
- FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.
- Proteomic Classification of Acute Leukemias by Alignment-Based Quantitation of LC-MS/MS Data Sets.
- High expression of neutrophil elastase predicts improved survival in pediatric Acute myeloid leukemia: a report from the Children's Oncology Group.
- Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with Acute myeloid leukemia: a SWOG report.
- Prevalence and prognostic implications of CEBPA mutations in pediatric Acute myeloid leukemia (AML): a report from the Children's Oncology Group.
- High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric Acute myeloid leukemia: a report from the ...
- Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML.
- MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors.
- The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia.
Schools
Wayne State University
Johns Hopkins University School Med
University Of Wa School Of Med
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
University of Washington -
Johns Hopkins University -
Wayne State University School of Medicine
Hospital
-
UW Medicine/Harborview Medical Center -
University of Washington Medical Center -
Seattle Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Sheldon Z. Goldberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tina M. Albertson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brandon K. Hadland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colleen S. Delaney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca A. Gardner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dana C. Matthews, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christopher T. Lux, MD
This Doctor is OpenDoctor Recommended.
|